KIC
BMY icon

Kensington Investment Counsel’s Bristol-Myers Squibb BMY Stock Holding History

Kensington Investment Counsel’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-24,248
Closed -$1.31M – 109
2024
Q1 		$1.31M Buy
24,248
+2,780
+13% +$142K 0.6% 56
2023
Q4 		$1.1M Sell
21,468
-3,689
-15% -$194K 0.58% 60
2023
Q3 		$1.46M Buy
25,157
+1,480
+6% +$90.7K 0.91% 38
2023
Q2 		$1.51M Buy
23,677
+2,739
+13% +$184K 0.96% 38
2023
Q1 		$1.45M Buy
20,938
+4,639
+28% +$327K 1.1% 38
2022
Q4 		$1.17M Sell
16,299
-92
-0.6% -$6.94K 0.92% 49
2022
Q3 		$1.17M Buy
16,391
+765
+5% +$55.5K 0.98% 48
2022
Q2 		$1.2M Sell
15,626
-272
-2% -$20.7K 1.03% 43
2022
Q1 		$1.16M Sell
15,898
-631
-4% -$42.4K 0.77% 60
2021
Q4 		$1.03M Buy
+16,529
New +$970K 0.6% 75
2021
Q2 		$993K Buy
14,864
+460
+3% +$30K 0.68% 72
2021
Q1 		$909K Buy
14,404
+1,186
+9% +$73.8K 0.68% 71
2020
Q4 		$820K Buy
+13,218
New +$813K 0.68% 70

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Kensington Investment Counsel's BMY Position: Q2 2024 in Review

Kensington Investment Counsel sold out of Bristol-Myers Squibb (BMY) in Q2 2024, closing a stake of 24,248 shares — an estimated $1.31M sold.

Kensington Investment Counsel first reported a position in BMY in Q4 2020 and held it in 13 quarters. The position peaked at $1.51M in Q2 2023. 2,148 funds tracked by Wall St. Rank hold BMY as of Q2 2024.

  • Kensington Investment Counsel reported no remaining Bristol-Myers Squibb position as of Q2 2024 after selling out during the quarter.
  • Kensington Investment Counsel sold 24,248 Bristol-Myers Squibb shares in Q2 2024, an estimated $1.31M.
  • Kensington Investment Counsel first reported a position in Bristol-Myers Squibb in Q4 2020 and held it in 13 quarters.
  • Kensington Investment Counsel's Bristol-Myers Squibb position peaked at $1.51M in Q2 2023.
  • 2,148 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2024.

Based on Kensington Investment Counsel's 13F filing for Q2 2024, filed 14 Aug 2024.